awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33401457-EEC41F26-808B-498E-88CD-A64FC742C838
Q33401457-EEC41F26-808B-498E-88CD-A64FC742C838
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401457-EEC41F26-808B-498E-88CD-A64FC742C838
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study.
P2860
Q33401457-EEC41F26-808B-498E-88CD-A64FC742C838
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401457-EEC41F26-808B-498E-88CD-A64FC742C838
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9497f4c9cbc97ddbccd59102ed8a027b5cd75e69
P2860
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.